deltatrials
Terminated PHASE1 INTERVENTIONAL NCT00856674

Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy

A Dose-Escalating Phase I Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous OPL-CCL2-LPM in Patients With IgA Nephropathy

Sponsor: Osprey Pharmaceuticals USA, Inc.

Conditions IGA Nephropathy Proteinuria
Interventions OPL-CCL2-LPM
Updated 5 times since 2017 Last updated: Jun 1, 2010 Started: Mar 31, 2009 Primary completion: Jun 30, 2010 Completion: Jun 30, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to resources and slow enrollment; not due to safety

This PHASE1 trial investigates IGA Nephropathy and Proteinuria and is currently terminated or withdrawn. Osprey Pharmaceuticals USA, Inc. leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE1

    First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Osprey Pharmaceuticals USA, Inc.
Data source: Osprey Pharmaceuticals USA, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations